Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M-R Taskinen

Showing results (211-220 of 269) with videos related to

Pageof 27
Sort By:
Diabetologia|January 13, 2012
Lowering of postprandial lipids in individuals with type 2 diabetes treated with alogliptin and/or pioglitazone: a randomised double-blind placebo-controlled studyB Eliasson, D Möller-Goede, K Eeg-Olofsson, et al.
Atherosclerosis|September 17, 1999
Intense physical training decreases circulating antioxidants and endothelium-dependent vasodilatation in vivoR Bergholm, S Mäkimattila, M Valkonen, et al.
Human Genetics|September 1, 1991
Polymorphisms of the gene encoding cholesterol ester transfer protein and serum lipoprotein levels in subjects with and without coronary heart diseaseH Tenkanen, P Koshinen, K Kontula, et al.
European Journal of Clinical Investigation|March 21, 1998
Glucose intolerance in familial combined hyperlipidaemia. EUFAM study groupJ Vakkilainen, K V Porkka, I Nuotio, et al.
Controlled Clinical Trials|February 1, 1997
A study to determine the response of coronary atherosclerosis to raising low high density lipoprotein cholesterol with a fibric-acid derivative in men after coronary bypass surgery. The rationale, design, and baseline characteristics of the LOCAT Study. Lopid Coronary Angiography TrialM Syvänne, M R Taskinen, Nieminen, et al.
Circulation|October 23, 1997
Prevention of the angiographic progression of coronary and vein-graft atherosclerosis by gemfibrozil after coronary bypass surgery in men with low levels of HDL cholesterol. Lopid Coronary Angiography Trial (LOCAT) Study GroupM H Frick, M Syvänne, M S Nieminen, et al.
Atherosclerosis|December 20, 1996
Cholesterol efflux from Fu5AH hepatoma cells induced by plasma of subjects with or without coronary artery disease and non-insulin-dependent diabetes: importance of LpA-I:A-II particles and phospholipid transfer proteinM Syvänne, G Castro, C Dengremont, et al.
Atherosclerosis|August 12, 1998
The 5A/6A polymorphism in the promoter of the stromelysin-1 (MMP-3) gene predicts progression of angiographically determined coronary artery disease in men in the LOCAT gemfibrozil study. Lopid Coronary Angiography TrialS E Humphries, L A Luong, P J Talmud, et al.
Diabetologia|December 22, 2007
USF1 gene variants contribute to metabolic traits in men in a longitudinal 32-year follow-up studyK Auro, K Kristiansson, B Zethelius, et al.
Biochimica Et Biophysica Acta|January 16, 1992
A novel polymorphism of apolipoprotein A-IV is the result of an asparagine to serine substitution at residue 127H Tenkanen, P Koskinen, J Metso, et al.
Pageof 27

Showing results (211-220 of 269) with videos related to

Sort By:
Pageof 27
Diabetologia|January 13, 2012
Lowering of postprandial lipids in individuals with type 2 diabetes treated with alogliptin and/or pioglitazone: a randomised double-blind placebo-controlled studyB Eliasson, D Möller-Goede, K Eeg-Olofsson, et al.
Atherosclerosis|September 17, 1999
Intense physical training decreases circulating antioxidants and endothelium-dependent vasodilatation in vivoR Bergholm, S Mäkimattila, M Valkonen, et al.
Human Genetics|September 1, 1991
Polymorphisms of the gene encoding cholesterol ester transfer protein and serum lipoprotein levels in subjects with and without coronary heart diseaseH Tenkanen, P Koshinen, K Kontula, et al.
European Journal of Clinical Investigation|March 21, 1998
Glucose intolerance in familial combined hyperlipidaemia. EUFAM study groupJ Vakkilainen, K V Porkka, I Nuotio, et al.
Controlled Clinical Trials|February 1, 1997
A study to determine the response of coronary atherosclerosis to raising low high density lipoprotein cholesterol with a fibric-acid derivative in men after coronary bypass surgery. The rationale, design, and baseline characteristics of the LOCAT Study. Lopid Coronary Angiography TrialM Syvänne, M R Taskinen, Nieminen, et al.
Circulation|October 23, 1997
Prevention of the angiographic progression of coronary and vein-graft atherosclerosis by gemfibrozil after coronary bypass surgery in men with low levels of HDL cholesterol. Lopid Coronary Angiography Trial (LOCAT) Study GroupM H Frick, M Syvänne, M S Nieminen, et al.
Atherosclerosis|December 20, 1996
Cholesterol efflux from Fu5AH hepatoma cells induced by plasma of subjects with or without coronary artery disease and non-insulin-dependent diabetes: importance of LpA-I:A-II particles and phospholipid transfer proteinM Syvänne, G Castro, C Dengremont, et al.
Atherosclerosis|August 12, 1998
The 5A/6A polymorphism in the promoter of the stromelysin-1 (MMP-3) gene predicts progression of angiographically determined coronary artery disease in men in the LOCAT gemfibrozil study. Lopid Coronary Angiography TrialS E Humphries, L A Luong, P J Talmud, et al.
Diabetologia|December 22, 2007
USF1 gene variants contribute to metabolic traits in men in a longitudinal 32-year follow-up studyK Auro, K Kristiansson, B Zethelius, et al.
Biochimica Et Biophysica Acta|January 16, 1992
A novel polymorphism of apolipoprotein A-IV is the result of an asparagine to serine substitution at residue 127H Tenkanen, P Koskinen, J Metso, et al.
Pageof 27